Colchicine

Inflammasome

32337546 ä. Colchicine as a potent anti-inflammatory treatment in COVID-19: can we teach an old dog new tricks?
32251729 ä. The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design
32344275 2020. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS)
32380315 2020. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis
32472681 2020. Why not to use colchicine in COVID-19? An old anti-inflammatory drug for a novel auto-inflammatory disease.
32445400 2020. Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
32511763 2020. Colchicine and COVID-19.
32503853 2020. COVID-19 infection in a patient with FMF: does colchicine have a protective effect?
32461554 2020. Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
32503855 2020. Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak.
32426001 2020. Colchicina: una herramienta terapeutica potencial frente a COVID-19. Experiencia en 5 pacientes.
32584431 2020. Colchicin Treatment of Covid-19 Presenting With Cutaneous Rash and Myopericarditis.
32492478 2020. Treating COVID-19 with colchicine in community healthcare setting.
32564213 2020. The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.
32564212 2020. Comment on "Colchicine may not be effective in COVID-19 infection; it may even be harmful?"
32556936 2020. Colchicine as a possible therapeutic option in COVID-19 infection.
32394215 2020. Colchicine may not be effective in COVID-19 infection; it may even be harmful?
32579195 2020. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
32579190 2020. Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)-An Old Drug With New Life?
33293273 2020. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.
32633162 2020. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature.
32732245 2020. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome.
32808940 2020. The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help?
32837853 2020. Colchicine in COVID-19: an Old Drug, New Use.
32838182 2020. Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review.
32855152 2020. Colchicine treatment in community healthcare setting to prevent severe COVID-19.
32855151 2020. Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre et al.
32860034 2020. Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).
32880032 2020. Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.
32937800 2020. Colchicine to Weather the Cytokine Storm in Hospitalized Patients with COVID-19.
33131470 2020. [Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: Colchicine versus ruxolitinib and secukinumab in open prospective randomized trial (COLORIT)].
33133323 2020. A Case Control Study to Evaluate the Impact of Colchicine on Patients Admitted to the Hospital with Moderate to Severe COVID-19 Infection.
33227067 2020. Colchicine, an anti-rheumatic agent, as a potential compound for the treatment of COVID-19.
33235833 2020. Colchicine in Dermatology: Rediscovering an Old Drug with Novel Uses.
33264297 2020. Colchicine reduces lung injury in experimental acute respiratory distress syndrome.